Making Science Simple
Complex Science is a pharmaceutical research think tank founded in 2020 at the onset of the COVID-19 pandemic. Our mission is to identify and accelerate breakthrough scientific discoveries for the benefit of humankind.
LATEST NEWS
COMPLEX SCIENCE TO DEVELOP NOVEL ORTHODONTIC DIAGNOSTIC TECHNOLOGY
2026
Advancing a key milestone, Complex Science announces it has commenced the development of a novel orthodontic diagnostic technology to be embedded into orthodontic aligners.
COMPLEX SCIENCE ENTERED INTO AN ASSET PURCHASE AGREEMENT WITH BIOQ, INC. FOR ITS GREY HAIR DRUG PROGRAM
2026
Complex Science announces it has entered into an asset purchase agreement with BioQ, Inc. (USA) for its development stage molecule for the treatment of grey hair (canities).
Complex Science Ventures Launches
September 2024
Complex Science’s early stage biotech innovation fund will focus on bringing breakthrough scientific discoveries from the lab to patients. The fund’s initial focus will be in dermatology and neurology.
Biotech Fund to be launched
2024
Complex Science will be launching an early stage biotech innovation fund. The fund will focus on bringing breakthrough scientific discoveries from the lab to patients. Our initial focus is in dermatology and neurology.
Launch of Groundbreaking Research of Scalp Neuropathy in Androgenetic Alopecia
2024
Complex Science to launch clinical research of scalp neuropathy in androgenetic alopecia.
OUR TEAM
By the Numbers
(Combined Experience)
Number of Clinical Studies Managed and Conducted
Number of Lectures Worldwide
Number of Publications
Number of Patent Applications
Number of Regulatory Applications: US FDA, European (EMA), Brazil (ANVISA), Japan, Korea, and China
WHAT WE DO
RESEARCH
We conduct extensive research to identify scientific trends and develop new scientific breakthroughs.
Our multi-disciplinary, team approach from physics, biology, medicine, mathematics and computer science combines desperate disciplines to leap innovation.
CONSULTANCY
We provide consultancy to pharmaceutical and biotechnology companies in developing innovative regulatory frameworks and clinical study designs to support accelerated approvals.
We provide consultancy in protecting innovation while striking a balance to increase patient access. Our team has extensive experience in patent portfolio development.
ADVOCACY
We advocate new breakthrough treatments that have met rigorous scientific review and are poised to benefit patients in need.
Our team, publishes extensively in peer-reviewed medical and scientific journals indexed by PubMed.
Our team, lectures at dozens of world renowned medical and scientific congresses.